Importantly, our findings may help to explain the recent observation that PCSK9 inhibition does not improve mortality in a high-dose LPS mouse model of endotoxemia39, which contrasts with most other evidence regarding the role of PCSK9 in endotoxemia and sepsis28–30,40. The gene discussed is PCSK9; the disease is serum lipopolysaccharide activity.